Summary An attempt has been made to reverse cachexia and to selectively deprive the tumour of metabolic substrates for energy production by feeding a ketogenic regime, since ketone bodies are considered important in maintaining homeostasis during starvation. As a model we have used a transplantable mouse adenocarcinoma of the colon (MAC 16) which produces extensive weight loss without a reduction in food intake. When mice bearing the MAC16 tumour were fed on diets in which up to 80% of the energy was supplied as medium chain triglycerides (MCT) with or without arginine 3-hydroxybutyrate host weight loss was reduced in proportion to the fat content of the diet, and there was also a reduction in the percentage contribution of the tumour to the final body weight. The increase in carcass weight in tumour-bearing mice fed high levels of MCT was attributable to an increase in both the fat and the non-fat carcass mass. Blood levels of free fatty acids (FFA) were significantly reduced by MCT addition. The levels of both acetoacetate and 3-hydroxybutyrate were elevated in mice fed the high fat diets, and tumour-bearing mice fed the normal diet did not show increased plasma levels of ketone bodies over the non-tumour-bearing group despite the loss of carcass lipids. Both blood glucose and plasma insulin levels were reduced in mice bearing the MAC16 tumour and this was not significantly altered by feeding the high fat diets. The elevation in ketone bodies may account for the retention of both the fat and the non-fat carcass mass. This is the first example of an attempt to reverse cachexia by a diet based on metabolic differences between tumour and host tissues, which aims to selectively feed the host at the expense of the tumour.
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Progressive weight loss is a characteristic feature of advanced Conyers et al., 1979b) . The lack of ketosis in cancer patients, cancer and is an important cause of death as well as despite the loss of body fat, may be related to an elevated contributing to the refractoriness of chemotherapy (Van Eys, basal metabolic rate (Theologides, 1979) and the high energy 1982). The cachectic syndrome is characterised by a expenditure by the liver in the recirculation of lactate into depletion of the host muscle and adipose mass and a glucose. The lack of ketosis may explain the increased total reduction in insulin secretion (Theologides, 1979; Goodlad et body protein turnover in cancer patients (Heber et al., 1982 (Heber et al., ) al., 1975 accompanied by a lower serum glucose level and and the decreased insulin secretory capacity. an elevation in serum unesterified fatty acids (Bibby et al., Tumours, especially those with a poor blood supply might 1987).
be expected to utilize glucose as the predominant metabolic
In contrast with acute starvation gluconeogenesis from fuel, since the Embden Meyerhof pathway is the only means both alanine (Waterhouse et al., 1979 ) and glycerol of ATP production which does not require oxygen. Thus (Lundholm et al., 1982) is increased in cachectic cancer fatty acids and ketone bodies might be expected to be patients and this is accompanied by an elevated Cori cycle metabolized poorly. Indeed, in a range of murine and human activity (Holroyde & Reichard, 1981) . The latter appears to tumours very low, or no activity of 3 oxo acid-CoA be due to an elevated tumour glycolysis leading to an transferase has been observed (Tisdale & Brennan, 1983) . increased lactate production, with a corresponding increase This enzyme is regarded as the key enzyme in ketone body in the proportion of glucose derived from lactate. metabolism. Thus a low carbohydrate ketogenic diet might During acute starvation mobilization of free fatty acids be expected to prevent host catabolism during cachexia and (FFA) from adipose tissue provides a source of energy for in addition reduce the rate of growth of tumours which organs such as muscle and liver. Excess FFA are converted depend on glucose as an energy source (Tisdale, 1982) . We in the liver to ketone bodies (acetoacetate and 3-hydroxy-have investigated this possibility in an experimental model of butyrate) which in turn serve as a source of energy for cachexia which utilizes the MAC16 adenocarcinoma of the extrahepatic tissues including the brain (Owen et al., 1967) . colon transplanted in NMR1 mice. This tumour, which is a This leads to a decrease in overall glucose requirement and a moderately well-differentiated adenocarcinoma, produces decrease in gluconeogenesis from alanine and lactate in the extensive weight loss in the host without a concurrent liver. In addition ketone bodies directly reduce protein reduction in food intake (Bibby et al., 1987) . degradation in muscle, possibly due to an inhibitory action on the oxidation of branched-chain amino acids, thus reducing the supply of gluconeogenic precursors. High ketone body levels also stimulate insulin secretion from the Materials and methods pancreas (Hawkins et al., 1971) .
Although extensive mobilization of adipose tissue occurs Chemicals were obtained from Sigma Chemical Co., Poole, in advanced cancer ketonuria is an uncommon phenomenon Dorset, UK, unless otherwise stated. A Wako NEFA C kit in both cancer patients (Conyers et al., 1979a) and in for FFA determination in plasma was obtained from Alpha tumour-bearing rodents (Bibby et al., 1987; Mider, 1951) .
Laboratories Ltd., Hampshire, UK. 3-Hydroxybutyrate, However, if either fasted cancer patients or tumour-bearing arginine salt was kindly donated by Solvay and Cie, mice are provided with an exogenous supply of fatty acids, Brussels, Belgium. Rat and mouse breeding diet, soya, ketonemia is observed suggesting no impairment of the liver sodium caseinate, rodent 006 premix and dicalcium in its ability to synthesize ketone bodies (Magee et al., 1979;  phosphate were all purchased from Pilsburys Ltd. (Table I ). The ketogenic diets were presented to the animals was determined using the o-toluidine reagent kit (Sigma). as a paste to minimise food scatter. Food consumption and Acetoacetate and 3-hydroxybutyrate levels were measured by water intake was monitored daily and food wastage was also the method of Mellanby and Williamson (1974) occurs without a significant change in total calories in carcass fat when compared with non tumour-bearing mice consumed (Table II) . Mice fed diets containing 80% MCT (P<0.01) which is proportional to the size of the tumour with or without 3-hydroxybutyrate show a significant (Bibby et al., 1987 compared with control non tumour-bearing mice when The total carcass water of both tumour-bearing and non expressed as an absolute weight (Table III) . However, when tumour-bearing mice does not vary with alterations in the the non-fat carcass weight is expressed as a percentage of the percentage of energy derived from MCT (Table III) . Thus final body weight there is no difference between tumourthe increase in weight of mice fed diets with increasing bearing and non tumour-bearing mice, despite the fact that proportions of energy supplied by MCT derives mainly from the former have lost over 20% of their body weight. This an increase in the carcass dry weight. suggests that the carcass dry weight is reduced in direct There is no significant alteration in the levels of proportion to the change in total carcass weight (Table III) .
circulatory FFA in tumour-bearing mice when compared Increasing the percentage of MCT in the diets of tumourwith non tumour-bearing mice fed the normal diet (Table  bearing mice leads to an increase in the carcass non-fat mass IV). With the exception of non tumour-bearing animals fed only with 80% MCT+3-hydroxybutyrate and there is no 68% MCT the FFA levels were all lower in both groups of difference from controls in the percentage contribution to animals when they were fed increasing levels of MCT. the total carcass weight with any of the diets.
However, tumour-bearing animals fed the 80% MCT diets The total fat content of the carcasses of mice fed have significantly higher levels of plasma FFA than the increasing proportions of triglycerides in the diet is shown in corresponding non tumour-bearing groups. ap <0.05 from corresponding non tumour-bearing group; bp<0.01 from corresponding non tumour-bearing group; Cp <0.05 from tumourbearing group on normal diet; dp <0.01 from tumour-bearing group on normal diet; ep<0.05 from non tumour-bearing group on normal diet; fp<0.01 from non tumour-bearing group on normal diet.
each of the dietary groups is shown in Table IV . The total on mice fed normal diets (Gabor et al., 1985) . A gain in ketone body concentration in tumour-bearing mice fed the body weight of patients with metastatic malignant disease normal diet is not elevated above that of non tumour-was reported when given a commercial fat emulsion by i.v. bearing mice, despite the decrease in carcass lipids. Feeding a infusion (Waterhouse & Nye, 1961) . In addition there was high fat diet to both tumour and non tumour-bearing mice evidence of nitrogen and potassium saving and movement results in a significant elevation of the plasma levels of both towards a positive caloric balance. acetoacetate and 3-hydroxybutyrate, over those fed the
In the present study weight loss was reduced by up to normal diet, although again there is no significant elevation 50% in NMR1 mice bearing the MAC16 adenocarcinoma of in the tumour-bearing groups over that of non tumourthe colon when they were fed a dietary regime with bearing groups for a given level of dietary fat. In fact for the increasing proportions of energy derived from medium chain 68% MCT diet the levels of acetoacetate are significantly triglycerides. Body composition analysis showed retention of lower in the tumour-bearing groups over that of the non both fat and non-fat carcass mass in animals fed high levels tumour-bearing groups. Despite the inclusion of large of MCT. No change was evident in the water content of the amounts of 3-hydroxybutyrate in the diets there is not carcasses between the different dietary groups. Despite the appreciable ketosis in these animals. This may be due to a high intake of triglycerides plasma levels of acetoacetate and high metabolic activity in mice, and to the excretion of large 3-hydroxybutyrate were not markedly elevated, presumably amounts of ketone bodies in the urine of mice fed high fat due to the high metabolic rate of the mice and excretion of diets (results not shown). Increasing the lipid content of the ketone bodies in the urine. Also the circulatory levels of diet causes a reduction in the 3-hydroxybutyrate:acetoacetate FFA were not elevated in either tumour-bearing or non ratio in both groups of mice. There is no effect of a high tumour-bearing mice fed the high fat diets, although there MCT diet on the level of 3-oxo acid-CoA transferase in the was some evidence for increased peripheral tissue deposition tumours. The level of this enzyme in the MAC16 tumour has of fat in tumour-bearing, but not in non tumour-bearing been shown to be much lower than that of normal colonic mice. This suggests increased catabolism of fat by #-mucosa (Tisdale & Brennan, 1986) . Thus the MAC16 oxidation. In view of the decreased oxygen tension in tumour has a low capacity to metabolize ketone bodies and tumours coupled with a decreased enzymatic capacity to deal this is not altered by dietary modulation.
with ketone bodies (Tisdale & Brennan, 1983 ) utilization of
The blood glucose level in tumour-bearing mice fed the both FFA and ketone bodies by the tumour might be normal diet is significantly lower than in non tumour-expected to be, minimal, which may account for the bearing mice (P<0.01) and the plasma insulin level is also reduction in tumour size observed. Normal tissues would be significantly reduced (Table IV) . Non tumour-bearing mice able to utilize both FFA and ketone bodies as an energy fed a diet with increasing proportions of energy derived from source and the hyperketonemia would promote nitrogen MCT do not have a significantly different blood glucose or conservation (Sherwin et al., 1975) , which in turn would plasma insulin level from those fed a normal diet, and, reduce gluconeogenic precursors to the liver. Loss of body tumour-bearing mice fed the high fat diets do not have a fat in non tumour-bearing mice fed high MCT diets is not significantly different blood glucose level from the due to a reduced dietary intake, but may be associated with corresponding non-tumour bearing groups. The presence of the decreased carbohydrate content of the diet. arginine 3-hydroxybutyrate in the diet does not affect plasma
We have previously shown (Bibby et al., 1987 ) that weight insulin levels.
loss produced by the MCA16 tumour is proportional to Lactate levels in tumour-bearing mice fed the normal diet tumour size and thus it is possible that the prevention of do not differ significantly from non tumour-bearing mice weight loss by the high fat regimes may be due to the (Table IV) . The effect of increasing triglyceride levels in the reduction in tumour size. However, a plot of tumour weight diet is to decrease the blood lactate level, although this is versus weight loss for mice fed the high fat diets shows a only significant with 68% MCT in the tumour-bearing mice.
significant increase in intercept (by F test) from those fed a There is no alteration in the plasma levels of pyruvate. This normal diet. Thus the high fat regime reduces weight loss to suggests decreased utilization of glucose with increasing fat a greater extent than might be anticipated from the consumption. reduction in tumour size. Moreover, the positive intercept on the tumour weight axis suggests that weight loss is totally prevented at small tumour masses by increasing the fat Discussion content of the diet.
The reduction in tumour size produced by diets containing The metabolism of a number of tumours is quantitatively 3-hydroxybutyrate does not result from a direct antitumour different from that of normal cells. Most tumours have a effect since in vitro arginine 3-hydroxybutyrate has no effect high dependence on glycolysis and are relatively deficient in on tumour growth at concentrations up to 6 mM. oxidative capacity, making it theoretically possible to Although nutritional support can improve the nutritional differentially feed the host and not the tumour. Using a rat status of the host large quantities of exogenous substrates transplantable mammary carcinoma Buzby et al. (1980) were are associated with an increased metabolic rate and able to show that when fat was provided as the primary stimulation of tumour growth. By increasing the lipid source of calories a more favourable host: tumour balance contribution to the nutritional regime we have shown that it was obtained, when measured by the relative rates of growth is possible to prevent host weight loss while reducing tumour of each. Isocaloric consumption of a diet high in fat and size. In addition such dietary modification may have a protein and low in carbohydrate significantly prolonged the synergistic action with conventional radiotherapy and survival of MCA-sarcoma bearing rats (Demetrakopoulos & chemotherapy, since initial results suggest a reduction in Rosenthall, 1982) and prevented anorexia in rats implanted necrosis and an increase in vasculature when animals are fed with Walker 256 carcinosarcoma (Enrione & Black, 1983) .
high levels of MCT (Tisdale & Brennan, unpublished Also dietary induced ketosis reduced the number of Bl16 results). Such a diet should be achievable clinically since it melanoma deposits in the lungs of C57BL/6 mice by twohas been reported (Phinney et at., 1983 ) that when normal thirds (Magee et at., 1979) although we have recently human subjects were fed a diet in which 85% of the calories reported a failure of systemic ketosis to control cachexia and were supplied as fat it was well tolerated and there was no growth rate of the Walker 256 carcinosarcoma in rats measurable impairment of hepatic, renal, cardiac or (Fearon et at., 1985) . However, the growth of a haemopoietic function.
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